# Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants

> **NCT04237246** · PHASE4 · COMPLETED · sponsor: **University of Manitoba** · enrollment: 20 (actual)

## Conditions studied

- Liver Failure

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT04237246
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2019-11-27
- **Final completion:** 2019-11-27
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04237246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04237246, "Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04237246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*